https://www.selleckchem.com/pr....oducts/msdc-0160.htm
RESULTS Out of 19 patients who met inclusion criteria, follow-up (Mean ± SD 7.8 ± 1.4 months), 12 were determined to have tumor progression while 7 with treatment response after 6 months following ICIs treatment. Only interval change of rADC was suggestive of treatment response. Patients with treatment response (6/7 86%) had interval increased rADC while 11/12 (92%) with tumor progression had decreased rADC (p=0.001). Interval change in rCBV, Ktrans, Vp, and Ve were not indicative of treatment response within 6 months. CONCLUSIONS In
Like
Comment
Share
